D
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
Price:
5 210
KRW
9.34%
Market Closed
Market Cap:
₩148.3B
Income Statement
Earnings Waterfall
DongKoo Bio & Pharma Co Ltd
DongKoo Bio & Pharma Co Ltd
Income Statement
DongKoo Bio & Pharma Co Ltd
DongKoo Bio & Pharma Co Ltd
Currency: KRW
| Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Interest Expense |
1 475
|
975
|
574
|
431
|
385
|
372
|
364
|
363
|
360
|
371
|
399
|
430
|
457
|
444
|
431
|
397
|
384
|
397
|
416
|
458
|
565
|
745
|
1 039
|
1 321
|
1 531
|
1 686
|
1 760
|
1 870
|
2 146
|
2 502
|
2 894
|
3 261
|
3 435
|
3 588
|
|
| Revenue |
95 943
N/A
|
100 469
+5%
|
101 124
+1%
|
104 518
+3%
|
106 045
+1%
|
103 086
-3%
|
104 837
+2%
|
106 757
+2%
|
109 607
+3%
|
117 307
+7%
|
125 235
+7%
|
130 204
+4%
|
136 097
+5%
|
140 566
+3%
|
139 216
-1%
|
141 431
+2%
|
144 080
+2%
|
149 031
+3%
|
155 149
+4%
|
166 045
+7%
|
176 858
+7%
|
187 109
+6%
|
194 988
+4%
|
196 174
+1%
|
199 507
+2%
|
201 715
+1%
|
215 686
+7%
|
231 409
+7%
|
240 395
+4%
|
253 710
+6%
|
249 275
-2%
|
243 743
-2%
|
242 552
0%
|
238 388
-2%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(37 899)
|
(39 202)
|
(40 247)
|
(42 339)
|
(43 161)
|
(42 187)
|
(43 447)
|
(43 887)
|
(45 551)
|
(50 411)
|
(54 547)
|
(57 881)
|
(60 360)
|
(60 353)
|
(58 598)
|
(58 229)
|
(58 922)
|
(61 219)
|
(62 705)
|
(66 201)
|
(70 506)
|
(73 446)
|
(77 011)
|
(77 786)
|
(77 586)
|
(78 851)
|
(83 493)
|
(89 217)
|
(94 328)
|
(98 364)
|
(97 245)
|
(95 064)
|
(93 759)
|
(94 746)
|
|
| Gross Profit |
58 044
N/A
|
61 268
+6%
|
60 877
-1%
|
62 179
+2%
|
62 883
+1%
|
60 898
-3%
|
61 390
+1%
|
62 871
+2%
|
64 057
+2%
|
66 897
+4%
|
70 688
+6%
|
72 324
+2%
|
75 738
+5%
|
80 214
+6%
|
80 618
+1%
|
83 202
+3%
|
85 158
+2%
|
87 812
+3%
|
92 444
+5%
|
99 844
+8%
|
106 352
+7%
|
113 662
+7%
|
117 977
+4%
|
118 388
+0%
|
121 921
+3%
|
122 864
+1%
|
132 193
+8%
|
142 192
+8%
|
146 067
+3%
|
155 347
+6%
|
152 030
-2%
|
148 678
-2%
|
148 794
+0%
|
143 643
-3%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(43 882)
|
(45 323)
|
(47 551)
|
(48 352)
|
(52 693)
|
(53 826)
|
(55 712)
|
(57 769)
|
(59 738)
|
(62 715)
|
(64 228)
|
(66 393)
|
(66 293)
|
(69 855)
|
(73 006)
|
(75 839)
|
(79 948)
|
(82 147)
|
(84 305)
|
(88 326)
|
(92 069)
|
(96 584)
|
(100 937)
|
(103 742)
|
(107 194)
|
(110 807)
|
(117 577)
|
(125 743)
|
(132 598)
|
(137 531)
|
(139 339)
|
(138 336)
|
(137 978)
|
(137 672)
|
|
| Selling, General & Administrative |
(40 643)
|
(41 790)
|
(43 586)
|
(44 401)
|
(47 950)
|
(49 365)
|
(50 993)
|
(52 246)
|
(54 012)
|
(55 586)
|
(56 364)
|
(57 470)
|
(56 664)
|
(58 851)
|
(61 710)
|
(64 261)
|
(67 835)
|
(70 798)
|
(73 483)
|
(77 864)
|
(82 139)
|
(87 497)
|
(91 825)
|
(94 543)
|
(97 944)
|
(100 700)
|
(105 943)
|
(114 397)
|
(121 123)
|
(126 505)
|
(130 040)
|
(128 861)
|
(127 793)
|
(126 950)
|
|
| Research & Development |
(2 727)
|
(2 989)
|
(3 681)
|
(3 673)
|
(4 463)
|
(4 312)
|
(4 414)
|
(5 136)
|
(5 265)
|
(6 604)
|
(7 292)
|
(8 372)
|
(9 092)
|
(10 473)
|
(10 751)
|
(11 025)
|
(11 526)
|
(10 697)
|
(10 114)
|
(9 702)
|
(9 131)
|
(8 263)
|
(8 258)
|
(8 326)
|
(8 361)
|
(9 220)
|
(10 752)
|
(10 449)
|
(10 378)
|
(9 641)
|
(8 380)
|
(8 403)
|
(9 286)
|
(9 799)
|
|
| Depreciation & Amortization |
(253)
|
(285)
|
(284)
|
(279)
|
(282)
|
(293)
|
(305)
|
(390)
|
(462)
|
(525)
|
(571)
|
(550)
|
(536)
|
(530)
|
(545)
|
(552)
|
(585)
|
(650)
|
(708)
|
(761)
|
(799)
|
(825)
|
(854)
|
(872)
|
(890)
|
(884)
|
(883)
|
(896)
|
(1 097)
|
(1 064)
|
(920)
|
(1 072)
|
(899)
|
(923)
|
|
| Other Operating Expenses |
(259)
|
(259)
|
0
|
0
|
0
|
144
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(320)
|
0
|
0
|
0
|
0
|
|
| Operating Income |
14 160
N/A
|
15 943
+13%
|
13 326
-16%
|
13 827
+4%
|
10 190
-26%
|
7 071
-31%
|
5 678
-20%
|
5 100
-10%
|
4 318
-15%
|
4 182
-3%
|
6 461
+54%
|
5 931
-8%
|
9 445
+59%
|
10 359
+10%
|
7 612
-27%
|
7 363
-3%
|
5 210
-29%
|
5 665
+9%
|
8 139
+44%
|
11 518
+42%
|
14 283
+24%
|
17 078
+20%
|
17 040
0%
|
14 646
-14%
|
14 727
+1%
|
12 056
-18%
|
14 616
+21%
|
16 449
+13%
|
13 469
-18%
|
17 816
+32%
|
12 691
-29%
|
10 342
-19%
|
10 816
+5%
|
5 970
-45%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
1 773
|
2 440
|
(582)
|
(622)
|
(927)
|
(673)
|
(588)
|
(495)
|
(365)
|
(571)
|
11 551
|
10 869
|
13 180
|
14 669
|
2 339
|
1 169
|
3 263
|
2 619
|
(379)
|
(881)
|
(7 782)
|
(9 335)
|
(8 897)
|
(6 872)
|
(3 964)
|
(3 870)
|
268
|
1 123
|
2 678
|
1 795
|
(7 217)
|
(11 179)
|
(2 984)
|
(4 616)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
141
|
0
|
141
|
141
|
0
|
1
|
2
|
2
|
2
|
1
|
6
|
6
|
6
|
7
|
1
|
0
|
0
|
0
|
2
|
(3)
|
(3)
|
0
|
(5)
|
(20)
|
(320)
|
0
|
(320)
|
(298)
|
4
|
4
|
|
| Gain/Loss on Disposition of Assets |
(529)
|
(20)
|
0
|
4
|
0
|
14
|
16
|
0
|
11
|
0
|
(2)
|
(8)
|
(83)
|
(82)
|
(82)
|
(76)
|
4
|
(5)
|
3 458
|
0
|
3 582
|
3 593
|
124
|
0
|
0
|
0
|
(0)
|
5
|
6
|
0
|
6
|
1
|
(0)
|
(0)
|
|
| Total Other Income |
(90)
|
(134)
|
412
|
400
|
88
|
168
|
73
|
225
|
244
|
423
|
230
|
473
|
661
|
366
|
425
|
175
|
54
|
139
|
114
|
3 570
|
(58)
|
(112)
|
(353)
|
(428)
|
(417)
|
(374)
|
(139)
|
98
|
106
|
75
|
(1 341)
|
(1 397)
|
(1 383)
|
(1 349)
|
|
| Pre-Tax Income |
15 315
N/A
|
18 230
+19%
|
13 156
-28%
|
13 611
+3%
|
9 492
-30%
|
6 581
-31%
|
5 320
-19%
|
4 971
-7%
|
4 206
-15%
|
4 035
-4%
|
18 242
+352%
|
17 267
-5%
|
23 207
+34%
|
25 314
+9%
|
10 300
-59%
|
8 639
-16%
|
8 537
-1%
|
8 425
-1%
|
11 333
+35%
|
14 207
+25%
|
10 025
-29%
|
11 225
+12%
|
7 916
-29%
|
7 343
-7%
|
10 343
+41%
|
7 813
-24%
|
14 741
+89%
|
17 654
+20%
|
15 938
-10%
|
19 686
+24%
|
3 819
-81%
|
(2 531)
N/A
|
6 454
N/A
|
10
-100%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
(1 697)
|
(2 353)
|
(2 213)
|
(2 240)
|
(1 521)
|
(979)
|
(751)
|
(803)
|
(448)
|
(419)
|
(3 141)
|
(2 962)
|
(3 607)
|
(4 247)
|
(1 160)
|
(704)
|
(1 188)
|
(969)
|
(2 007)
|
(2 842)
|
(2 384)
|
(2 824)
|
(1 302)
|
(1 092)
|
(1 658)
|
(990)
|
(2 932)
|
(3 365)
|
(2 954)
|
(4 382)
|
(1 828)
|
(593)
|
(560)
|
695
|
|
| Income from Continuing Operations |
13 618
|
15 877
|
10 943
|
11 371
|
7 971
|
5 602
|
4 569
|
4 169
|
3 759
|
3 616
|
15 101
|
14 305
|
19 599
|
21 067
|
9 140
|
7 933
|
7 350
|
7 456
|
9 327
|
11 365
|
7 641
|
8 401
|
6 614
|
6 251
|
8 685
|
6 823
|
11 808
|
14 289
|
12 984
|
15 304
|
1 991
|
(3 123)
|
5 894
|
705
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
18
|
21
|
32
|
45
|
70
|
69
|
65
|
|
| Net Income (Common) |
13 068
N/A
|
15 327
+17%
|
10 943
-29%
|
11 371
+4%
|
7 971
-30%
|
5 602
-30%
|
4 569
-18%
|
4 169
-9%
|
3 759
-10%
|
3 616
-4%
|
15 101
+318%
|
14 305
-5%
|
19 599
+37%
|
21 067
+7%
|
9 140
-57%
|
7 933
-13%
|
7 350
-7%
|
7 456
+1%
|
9 327
+25%
|
11 365
+22%
|
7 641
-33%
|
8 401
+10%
|
6 614
-21%
|
6 251
-5%
|
8 685
+39%
|
6 823
-21%
|
11 812
+73%
|
14 307
+21%
|
13 005
-9%
|
15 337
+18%
|
2 036
-87%
|
(3 053)
N/A
|
5 963
N/A
|
770
-87%
|
|
| EPS (Diluted) |
594
N/A
|
666.39
+12%
|
497.4
-25%
|
437.34
-12%
|
306.57
-30%
|
193.17
-37%
|
163.17
-16%
|
143.75
-12%
|
129.62
-10%
|
124.68
-4%
|
520.72
+318%
|
510.89
-2%
|
699.96
+37%
|
752.39
+7%
|
326.42
-57%
|
841.24
+158%
|
259.78
-69%
|
263.53
+1%
|
330.05
+25%
|
406.32
+23%
|
274.8
-32%
|
302.55
+10%
|
238.29
-21%
|
226.29
-5%
|
314.39
+39%
|
246.98
-21%
|
427.63
+73%
|
522.01
+22%
|
475.53
-9%
|
563.08
+18%
|
74.54
-87%
|
-112.9
N/A
|
209.49
N/A
|
28.48
-86%
|
|
Switch to:
Switch to:
See Also
Discover More
